Skip to main content
SpringerLink
Log in

Heart Transplant Patient Selection and Preparation

  • Chapter
  • First Online:
Anesthesia and Perioperative Care for Organ Transplantation

Abstract

Appropriate risk stratification of patients with end-stage heart failure is critical for transplant patient selection and allocation of scarce donor organs. The selection of cardiac transplant candidates is a multidisciplinary process that continues to evolve. The ultimate decision about whether to place a patient on the heart transplant waiting list is made by a multidisciplinary team and is based on a combination of the patient’s heart failure severity, comorbidities that may increase perioperative and long-term risk, social support system, and clinical judgment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Roger VL, Go AS, Lloyd-Jones DM. Executive summary: heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation. 2012;125:188–97.

    Article  PubMed  Google Scholar 

  2. Stehlik J, Edwards LB, Kucheryavaya AY, et al. International Society of Heart and Lung Transplantation. The registry of the international society for heart and lung transplantation: 29th official adult heart transplant report—2012. J Heart Lung Transplant. 2012;31:1052–64.

    Article  PubMed  Google Scholar 

  3. Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010. Circulation. 2010;122(2):173–83.

    Article  PubMed  Google Scholar 

  4. Lund LH, Edwards LB, Kucheryavaya AY, et al. International Society for Heart and Lung Transplantation. The registry of the international society for heart and lung transplantation: thirtieth official adult heart transplant report—2013; focus theme: age. J Heart Lung Transplant. 2013;32(10):951–64.

    Article  PubMed  Google Scholar 

  5. Yancy CW, Jessup M, Bozkurt B, et al. American College of Cardiology Foundation; American Heart association task force on practice guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2013;62(16):e147–239.

    Article  PubMed  Google Scholar 

  6. Mancini DM, Eisen H, Kussmaul W, et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83:778.

    Article  CAS  PubMed  Google Scholar 

  7. O'Neill JO, Young JB, Pothier CE, Lauer MS. Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers. Circulation. 2005;111:2313.

    Article  PubMed  Google Scholar 

  8. Butler J, Khadim G, Paul KM, et al. Selection of patients for heart transplantation in the current era of heart failure therapy. J Am Coll Cardiol. 2004;43:787.

    Article  PubMed  Google Scholar 

  9. Goda A, Lund LH, Mancini D. The Heart Failure Survival Score outperforms the peak oxygen consumption for heart transplantation selection in the era of device therapy. J Heart Lung Transplant. 2011;30:315.

    Article  PubMed  Google Scholar 

  10. Ferreira AM, Tabet JY, Frankenstein L, et al. Ventilatory efficiency and the selection of patients for heart transplantation. Circ Heart Fail. 2010;3(3):378–86.

    Article  PubMed  Google Scholar 

  11. MacGowan GA, Janosko K, Cecchetti A, Murali S. Exercise-related ventilatory abnormalities and survival in congestive heart failure. Am J Cardiol. 1997;79(9):1264–6.

    Article  CAS  PubMed  Google Scholar 

  12. Guazzi M, Arena R, Ascione A, Piepoli M, Guazzi MD. Gruppo di Studio Fisiologia dell'Esercizio, Cardiologia dello Sport e Riabilitazione Cardiovascolare of the Italian Society of Cardiology. Exercise oscillatory breathing and increased ventilation to carbon dioxide production slope in heart failure: an unfavorable combination with high prognostic value. Am Heart J. 2007;153(5):859–67.

    Article  PubMed  Google Scholar 

  13. Arena R, Myers J, Guazzi M. The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review. Heart Fail Rev. 2008;13(2):245–69.

    Article  PubMed  Google Scholar 

  14. Aaronson KD, Schwartz JS, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660.

    Article  CAS  PubMed  Google Scholar 

  15. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424.

    Article  PubMed  Google Scholar 

  16. Costard-Jäckle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 1992;19(1):48–54.

    Article  PubMed  Google Scholar 

  17. Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. J Am Coll Cardiol. 1996;28(7):1775–80.

    Article  CAS  PubMed  Google Scholar 

  18. Ichinose F, Roberts Jr JD, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential. Circulation. 2004;109(25):3106–11.

    Article  PubMed  Google Scholar 

  19. Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation. 1994;90(6):2780–5.

    Article  CAS  PubMed  Google Scholar 

  20. Murali S, Kormos RL, Uretsky BF, Schechter D, Reddy PS, Denys BG, Armitage JM, Hardesty RL, Griffith BP. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J. 1993;126(4):896–904.

    Article  CAS  PubMed  Google Scholar 

  21. Canver CC, Chanda J. Milrinone for long-term pharmacologic support of the status 1 heart transplant candidates. Ann Thorac Surg. 2000;69(6):1823–6.

    Article  CAS  PubMed  Google Scholar 

  22. Pacher R, Stanek B, Hülsmann M, Berger R, Siegel A, Daneschvar H, Rödler S, Frey B, Grimm M, Laufer G. Prostaglandin E1—bridge to cardiac transplantation technique, dosage, results. Eur Heart J. 1997;18(2):318–29.

    Article  CAS  PubMed  Google Scholar 

  23. Kellerman L, Neugut A, Burke B, Mancini D. Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population. Am J Cardiol. 2009;103:562.

    Article  PubMed  Google Scholar 

  24. Oliveira GH, Hardaway BW, Kucheryavaya AY, Stehlik J, Edwards LB, Taylor DO. Characteristics and survival of patients with chemotherapy-induced cardiomyopathy undergoing heart transplantation. J Heart Lung Transplant. 2012;31(8):805–10.

    Article  PubMed  Google Scholar 

  25. Blanche C, Blanche DA, Kearney B, et al. Heart transplantation in patients seventy years of age and older: a comparative analysis of outcome. J Thorac Cardiovasc Surg. 2001;121:532–41.

    Article  CAS  PubMed  Google Scholar 

  26. Zuckermann A, Dunkler D, Deviatko E, et al. Longterm survival (10 years) of patients 60 years with induction therapy after cardiac transplantation. Eur J Cardiothorac Surg. 2003;24:283–91.

    Article  PubMed  Google Scholar 

  27. Demers P, Moffatt S, Oyer PE, Hunt SA, Reitz BA, Robbins RC. Long-term results of heart transplantation in patients older than 60 years. J Thorac Cardiovasc Surg. 2003;126:224–31.

    Article  PubMed  Google Scholar 

  28. Mehra MR, Kobashigawa J, Starling R, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates—2006. J Heart Lung Transplant. 2006;25:1024.

    Article  PubMed  Google Scholar 

  29. Leitz K, John R, Burke EA, et al. Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation. Transplantation. 2001;72:277–83.

    Article  Google Scholar 

  30. Fasol R, Schindler M, Schumacher B, et al. The influence of obesity on perioperative morbidity: retrospective study of 502 aortocoronary bypass operations. Thorac Cardiovasc Surg. 1992;40:126–9.

    Article  CAS  PubMed  Google Scholar 

  31. Miller LW. Listing criteria for cardiac transplantation: results of an American Society of Transplant Physicians – National Institutes of Health Conference. Transplantation. 1998;66:947–51.

    Article  CAS  PubMed  Google Scholar 

  32. Lang CC, Beniaminovitz A, Edwards N, Mancini DM. Morbidity and mortality in diabetic patients following cardiac transplantation. J Heart Lung Transplant. 2003;22:244.

    Article  PubMed  Google Scholar 

  33. Russo MJ, Chen JM, Hong KN, et al. Columbia University Heart Transplant Outcomes Research Group. Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database. Circulation. 2006;114(21):2280–7.

    Article  PubMed  Google Scholar 

  34. Almuti K, Haythe J, Tsao L, Naka Y, Mancini D. Does renal function deteriorate more rapidly in diabetic cardiac transplant recipients? Transplantation. 2007;83(5):550–3.

    Article  PubMed  Google Scholar 

  35. Radovancevic B, Poindexter S, Birovljev S, et al. Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients. Eur J Cardiothorac Surg. 1990;4:309–12.

    Article  CAS  PubMed  Google Scholar 

  36. Mehra MR, Uber PA, Prasad A, Scott RL, Park MH. Recrudescent tobacco exposure following heart transplantation: clinical profiles and relationship with athero-thrombosis risk markers. Am J Transplant. 2005;5:1137–40.

    Article  PubMed  Google Scholar 

  37. Basile A, Bernazzali S, Diciolla F, et al. Risk factors for smoking abuse after heart transplantation. Transplant Proc. 2004;36:641–2.

    Article  CAS  PubMed  Google Scholar 

  38. Miguet M, Monnet E, Vanlemmens C, et al. Predictive factors of alcohol relapse after orthotopic liver transplantation for alcoholic liver disease. Gastroenterol Clin Biol. 2004;28:845–51.

    Article  PubMed  Google Scholar 

  39. Dew MA, Kormos RL, Roth LH, Murali S, DiMartini A, Griffith BP. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant. 1999;18:549–62.

    Article  CAS  PubMed  Google Scholar 

  40. Maldonado JR, Dubois HC, David EE, Sher Y, Lolak S, Dyal J, Witten D. The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates. Psychosomatics. 2012;53:123–32.

    Article  PubMed  Google Scholar 

  41. Hosenpud JD, Pamidi SR, Fiol BS, et al. Outcomes in patients who are hepatitis B surface antigen-positive before transplantation: an analysis and study using the joint ISHLT/UNOS thoracic registry. J Heart Lung Transplant. 2000;19:781.

    Article  CAS  PubMed  Google Scholar 

  42. Lunel F, Cadranel JF, Rosenheim M, et al. Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survival. Gastroenterology. 2000;119:1064.

    Article  CAS  PubMed  Google Scholar 

  43. Uriel N, Jorde UP, Cotarlan V, et al. Heart transplantation in human immunodeficiency virus-positive patients. J Heart Lung Transplant. 2009;28:667.

    Article  PubMed  Google Scholar 

  44. http://optn.transplant.hrsa.gov/policiesAndBylaws/policies.asp. Accessed 16 Aug 2013.

  45. Yancy CW, et al. Improved outcomes in patients awaiting heart transplantation: making the case that status 2 patients should not undergo transplantation. The Journal of heart and lung transplantation. 2002;21(1):69.

    Article  Google Scholar 

  46. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986;314(24):1547–52.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University Wexner Medical Center, 473 W 12th Ave, Columbus, OH, 43210, USA

    Brent C. Lampert D.O.

  2. Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

    Ravi Ramani M.D.

Authors
  1. Brent C. Lampert D.O.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ravi Ramani M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brent C. Lampert D.O. .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

    Kathirvel Subramaniam

  2. Department of Anesthesiology The Clinical and Translational Science Institute The McGowan Institute for Regenerative Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

    Tetsuro Sakai

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lampert, B.C., Ramani, R. (2017). Heart Transplant Patient Selection and Preparation. In: Subramaniam, K., Sakai, T. (eds) Anesthesia and Perioperative Care for Organ Transplantation. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6377-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6377-5_11

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-6375-1

  • Online ISBN: 978-1-4939-6377-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation